Anti-osteolytic therapy preserves trabecular architecture and mechanical properties of bone in tumor osteolysis;Eine Antiosteolytische Therapie bewahrt die Trabekelstruktur und die mechanischen Eigenschaften des Knochens in Tumorosteolysen

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 138, Issue 2, 2000, Pages 146-151

  Kurth, A A ^a   Kim, S Z ^a   Bauss, F ^a   Muller, R ^a   Hovy, L ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Bisphosphonate treatment; Bone quality; Trabecular architecture; Tumor osteolysis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MINERAL; BONE STRENGTH; BONE STRUCTURE; BONE TUMOR; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; NONHUMAN; OSTEOLYSIS; RAT; TORSION; TRABECULAR BONE; TREATMENT OUTCOME;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE NEOPLASMS; BONE RESORPTION; CARCINOMA 256, WALKER; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASM TRANSPLANTATION; OSTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033831946     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-10130     Document Type: Article

References (43)

1. Osteoklastenbiologie
2. Ibandronate in malignant bone disease and osteoporosis-preclinical results
3. Metastatic bone disease: Clinical and therapeutic aspects
4. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices
5. Skeletal complications of malignancy
6. Dual-energy Ct-scan quantification of recalcification in osteotyses of the vertebral body due to mammary carcinoma in the course of antineoplastic treatment
7. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
8. Knochendichtemessung mit Zwei-Spektren-Methoden
9. Effect of large dosis of olpadronate (dimethyl-Pamidronate) on mineral density, cross-secional architecture, and mechanical properties of rat femurs
10. The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45ca kinetics in the intact rat
11. The role of the orthopaedic surgeon in the treatment of bone pain
12. Advances in the noninvasive assessment of bone density, quality, and structure
13. Effects of disodium etidronate in murine tumor models
14. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases bone mass and mechanical properties
15. Predicting pathologie fracture risk in the management of metastatic bone defects
16. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
17. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat
18. Clodronate decreases the frequency of skeletal metastases in women with breast cancer
19. Three-dimensional in vivo morphometry of trabecular bone in the OVX rat model of osteoporosis
20. Experimental studies on the influence of the bisphosphonate CL2MBP on bone conditioned media and their effect on tumor cell growth in vitro
21. Preventative treatment with ibandronate improves bone quality in rat femora with tumor-induced osteolytic defects
22. Treatment with Ibandronate preserves bone in experimental tumor-induced bone loss
23. An animal model for the evaluation of biomechanical and densitometric properties of tumor induced bone loss
24. Early estrogen replacement therapy reverses the rapid loss of trabecutar bone Volume and prevents further deterioration of connectivity in the rat
25. Improved Bone Biomechanical Properties in Rats after Oral Xylitol Administration
26. Quantitative structural analysis of human cancellous bone
27. Micro-compression: A novel technique for the nondestructive assessment of local bone failure
28. Morphometrie analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography
29. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice
30. Three-dimensional methods for quantification of cancellous bone architecture
31. Tumorbone interactions in skeletal metastasis
32. Bone histomorphometry: Standardization of nomenclature, symbols, and units
33. The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study
34. Osteodensitometry of vertebral metastases after radiotherapy using quantitative computed tomography
35. Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer
36. Metastatic breast cancer
37. A microtomographic system for the nondestructive evaluation of bone architecture
38. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
39. Statistisches Bundesamt (Hrsg.).: Statistisches Jahrbuch der Bundesrepublik Deutschland 1995 (Gesundheitswesen)
40. Effects of 4-amino-1-hydroxybutilidene bisphosphonate on bone biomechanics in rats
41. Distribution of 3-amino-1-hydroxypropane-1,1-diphosphonicacid in rats and effects on rat osteosarcoma
42. Evaluation of trabecular bone morphometry: Comparison of micro-computed tomography and histomorphometry in the rat proximal tibia
43. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2